Literature DB >> 25246341

Preliminary study of Huai Qi Huang granules delay the development of primary glomerular diseases in human.

Shao-Bin Duan1, Peng Pan, Qian Xu, Xiejia Li, Na Liu, Jun Xu.   

Abstract

OBJECTIVE: To evaluate the effects of Huai Qi Huang (HQH) granules on primary glomerulonephritis patients, and to discuss its possible mechanisms.
METHOD: Sixteen patients diagnosed with primary glomerular disease between December 2011 and December 2012 were enrolled. Their blood and urine samples were collected at day 0 (the baseline levels), 30, and 90 of receiving HQH granules orally. Levels of creatinine and cystatin C (Cys-C) in serum and urine, and total protein and albumin in urine were measured by automatic biochemical analyzer. Neutrophil gelatinase-associated lipocalin (NGAL) in serum and urine was tested by ELISA; serum malondialdehyde (MDA) was measured by thiobarbituric acid method, the erythrocyte count in urine was calculated under light microscope.
RESULTS: Serum levels of creatinine, MDA, Cys-C and NGAL at day 30 and 90 were significantly lower than the baseline levels. Urinary levels of Cys-C, NGAL, total protein, albumin and erythrocyte counts were also decreased; level of estimated glomerular filtration (eGFR) was increased.
CONCLUSION: HQH granules have certain effect on delaying the development of primary glomerular disease with mild proteinuria and hematuresis in patients. This study may supply a new treatment for primary glomerular diseases.

Entities:  

Keywords:  Chronic kidney disease; Huai Qi Huang granules; primary glomerular disease

Mesh:

Substances:

Year:  2014        PMID: 25246341     DOI: 10.3109/0886022X.2014.952746

Source DB:  PubMed          Journal:  Ren Fail        ISSN: 0886-022X            Impact factor:   2.606


  5 in total

1.  Effects of Huaiqihuang Granules Adjuvant Therapy in Children with Primary Nephrotic Syndrome.

Authors:  Ping Zhou; Qiong Xiao; Lan Chen; Zhi-Jie Zou; Yu-Qing Wang; Lin Zhu; Hai-Yan Yu; Cheng-Guang Zhao; Yu-Bin Wu; Xuan-Yi Du
Journal:  Open Life Sci       Date:  2019-12-31       Impact factor: 0.938

Review 2.  Efficacy and safety of Huaiqihuang granule as adjuvant treatment for primary nephrotic syndrome in children: a meta-analysis and systematic review.

Authors:  Jiao Lin; Li-Min Huang; Jing-Jing Wang; Jian-Hua Mao
Journal:  World J Pediatr       Date:  2021-06-01       Impact factor: 2.764

3.  Effect of Huai Qi Huang on Epithelial-Mesenchymal Transition of Renal Tubular Epithelial Cells through miR-200a.

Authors:  Jinyun Pu; Yu Zhang; Jianhua Zhou
Journal:  Evid Based Complement Alternat Med       Date:  2016-01-14       Impact factor: 2.629

Review 4.  The Effect of Chinese Traditional Medicine Huaiqihuang (HQH) on the Protection of Nephropathy.

Authors:  Xueyan Zhang; Yiyu Cheng; Qian Zhou; Haojie Huang; Yinmiao Dong; Yang Yang; Mingyi Zhao; Qingnan He
Journal:  Oxid Med Cell Longev       Date:  2020-06-16       Impact factor: 6.543

5.  Computational Systems Pharmacology, Molecular Docking and Experiments Reveal the Protective Mechanism of Li-Da-Qian Mixture in the Treatment of Glomerulonephritis.

Authors:  Wei Zhou; Yugen Sha; Jingxia Zeng; Xiaoyue Zhang; Aihua Zhang; Xuhua Ge
Journal:  J Inflamm Res       Date:  2021-12-16
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.